Screener
BridgeBio Pharma BBIO Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from BridgeBio Pharma’s reported figures.
The source filing: BridgeBio Pharma’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001743881-26-000027
FAQ
- What is BridgeBio Pharma's free cash flow?
- BridgeBio Pharma (BBIO) reported free cash flow of -$71.54M in Q2 2026.
- How has BridgeBio Pharma's free cash flow changed year-over-year?
- BridgeBio Pharma's free cash flow increased by 12.0% year-over-year, from -$81.28M to -$71.54M.
- What is the long-term trend for BridgeBio Pharma's free cash flow?
- Over 3 years (2021 to 2025), BridgeBio Pharma's free cash flow has grown at a -4.4% compound annual growth rate (CAGR), from -$511.18M to -$447.01M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about BridgeBio Pharma's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude